CCL2 and neoplasm: The loss and mutation of TP53 in tumor cells also induce the production of various chemokines, such as CCL2 and CXCL10, and immunosuppressive regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) are recruited into the tumor microenvironment [76,77].